Cidara Therapeutics Inc. (CDTX) Fundamentals

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates.
SHARE INFORMATION
Market Cap$ 48,341,553
Shares Outstanding69,049,497
Float67,965,226
Percent Float98.43%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 49,572,000
Latest Fiscal EPS$ -0.86
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions128
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months376,304
Institutional Holdings Percent49.2%
Institutional Sold Previous 3 Months4,879,635
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months196,000
Insider Holdings Percent3.5
Insider Sold Previous 3 Months-
Insider Shares Owned2,433,997
TRADING INFO
52 Week High$ 2.39
52 Week Low$ 0.40
52 Week High Change$ -58.57
21 Day Moving Average$ 0.7194
21 Day Extended Moving Average$ 0.69552
50 Day Moving Average$ 0.5916
50 Day Extended Moving Average$ 0.653488
200 Day Moving Average$ 0.921076
200 Day Extended Moving Average$ 0.950924
10 Day Average Volume1,417,368
20 Day Average Volume897,096
30 Day Average Volume705,566
50 Day Average Volume557,522
Alpha-0.030170
Beta1.5309
Standard Deviation0.211326
R20.131280
7 Day Price Change$ -0.0849
7 Day Percent Change-10.82%
21 Day Price Change$ -0.0064
21 Day Percent Change-0.91%
30 Day Price Change$ 0.2241
30 Day Percent Change47.08%
Month to Date Price Change$ -0.0849
Month to Date Percent Change-10.82%
Quarter to Date Price Change$ 0.2115
Quarter to Date Percent Change43.29%
180 Day Price Change$ -0.1389
180 Day Percent Change-16.56%
200 Day Price Change$ -0.2649
200 Day Percent Change-27.45%
Year to Date Price Change$ -0.5699
Year to Date Percent Change-44.87%

Cidara Therapeutics Inc. (CDTX) Key Ratios

PROFITABILITY
EBIT Margin-77.9%
EBITDA Margin-77.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count-80.98%
Gross Margin0.0%
Profit Margin TOT-80.98%
INCOME STATEMENTS
Revenue$ 21,410,000
Revenue Per Share$ 0.3101
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book9.80
Total Debt To Equity0.70
Int Coverage-410.60
Current Ratio1.60
Leverage Ratio5.00
Quick Ratio1.40
Long Term Debt To Capital0.17
VALUATION MEASURES
PE Ratio-0.90
Enterprise Value$ 15,528,552
Price to Sales2.2579
Price to Free Cash-1.00
PE High Last 5 Years-1.40
Price To Book9.80
Price To Cash Flow0.00
PE Low Last 5 Years-1.70
Price to Tangible Book9.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.40
Invoice Turnover0.00
Assets Turnover0.40
Return Assets-79.74
Return on Equity-1,259.15
Return on Capital-467.58

Cidara Therapeutics Inc. (CDTX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOJeffrey Stein
Emplyoees89
Last AuditUE
CIK0001610618
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address6310 Nancy Ridge Drive
Suite 101
San Diego, CA 92121
Websitehttps://www.cidara.com
Facsimile-
Telephone+1 858 752-6170
Emailinfo@cidara.com


Your Recent History
NASDAQ
CDTX
Cidara The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.